{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,26]],"date-time":"2026-09-26T05:17:37Z","timestamp":1790399857066,"version":"4.1.0"},"reference-count":44,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2016,4,1]],"date-time":"2016-04-01T00:00:00Z","timestamp":1459468800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"funder":[{"DOI":"10.13039\/100000069","name":"National Institute of Arthritis and Musculoskeletal and Skin Diseases","doi-asserted-by":"publisher","award":["P60 AR062755"],"award-info":[{"award-number":["P60 AR062755"]}],"id":[{"id":"10.13039\/100000069","id-type":"DOI","asserted-by":"publisher"}]},{"name":"NIH\u2014NCATS","award":["UL1 TR000062"],"award-info":[{"award-number":["UL1 TR000062"]}]},{"name":"South Carolina COBRE","award":["P30 GM103342"],"award-info":[{"award-number":["P30 GM103342"]}]}],"content-domain":{"domain":["clinicalkey.jp","clinicalkey.com","clinicalkey.es","translationalres.com","clinicalkey.com.au","clinicalkey.fr","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Translational Research"],"published-print":{"date-parts":[[2016,4]]},"DOI":"10.1016\/j.trsl.2015.12.009","type":"journal-article","created":{"date-parts":[[2015,12,19]],"date-time":"2015-12-19T15:00:02Z","timestamp":1450537202000},"page":"99-111","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":11,"special_numbering":"C","title":["M10, a caspase cleavage product of the hepatocyte growth factor receptor, interacts with Smad2 and demonstrates antifibrotic properties in\u00a0vitro and in\u00a0vivo"],"prefix":"10.1016","volume":"170","author":[{"given":"Ilia","family":"Atanelishvili","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuichiro","family":"Shirai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tanjina","family":"Akter","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Taylor","family":"Buckner","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Atsushi","family":"Noguchi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Richard M.","family":"Silver","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Galina S.","family":"Bogatkevich","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.trsl.2015.12.009_bib1","doi-asserted-by":"crossref","first-page":"607","DOI":"10.1097\/BOR.0000000000000110","article-title":"Emerging cellular and molecular targets in fibrosis: implications for scleroderma pathogenesis and targeted therapy","volume":"26","author":"Castelino","year":"2014","journal-title":"Curr Opin Rheumatol"},{"key":"10.1016\/j.trsl.2015.12.009_bib2","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1517\/13543784.2014.848852","article-title":"Novel investigational agents for the treatment of scleroderma","volume":"23","author":"McMahan","year":"2014","journal-title":"Expert Opin Investig Drugs"},{"key":"10.1016\/j.trsl.2015.12.009_bib3","doi-asserted-by":"crossref","first-page":"268","DOI":"10.1096\/fj.02-0442fje","article-title":"Hepatocyte growth factor counteracts transforming growth factor-beta1, through attenuation of connective tissue growth factor induction, and prevents renal fibrogenesis in 5\/6 nephrectomized mice","volume":"17","author":"Inoue","year":"2003","journal-title":"FASEB J"},{"key":"10.1016\/j.trsl.2015.12.009_bib4","doi-asserted-by":"crossref","first-page":"580","DOI":"10.1096\/fj.04-1535fje","article-title":"HGF reduces advancing lung fibrosis in mice: a potential role for MMP-dependent myofibroblast apoptosis","volume":"19","author":"Mizuno","year":"2005","journal-title":"FASEB J"},{"key":"10.1016\/j.trsl.2015.12.009_bib5","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1089\/hum.2012.098","article-title":"Targeted gene transfer of hepatocyte growth factor to alveolar type II epithelial cells reduces lung fibrosis in rats","volume":"24","author":"Gazdhar","year":"2013","journal-title":"Hum Gene Ther"},{"key":"10.1016\/j.trsl.2015.12.009_bib6","doi-asserted-by":"crossref","first-page":"2432","DOI":"10.1002\/art.22713","article-title":"Impairment of the antifibrotic effect of hepatocyte growth factor in lung fibroblasts from African Americans: possible role in systemic sclerosis","volume":"56","author":"Bogatkevich","year":"2007","journal-title":"Arthritis Rheum"},{"issue":"10 Suppl.","key":"10.1016\/j.trsl.2015.12.009_bib7","first-page":"2907","article-title":"D1398G variant of hepatocyte growth factor receptor\u2014a potential biomarker of severe interstitial lung disease in African American scleroderma patients","volume":"65","author":"Atanelishvili","year":"2013","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.trsl.2015.12.009_bib8","first-page":"1383","article-title":"Biosynthesis of the protein encoded by the c-met proto-oncogene","volume":"4","author":"Giordano","year":"1989","journal-title":"Oncogene"},{"key":"10.1016\/j.trsl.2015.12.009_bib9","doi-asserted-by":"crossref","first-page":"405","DOI":"10.1136\/jclinpath-2015-203050","article-title":"Gene of the month: MET","volume":"68","author":"Skead","year":"2015","journal-title":"J Clin Pathol"},{"key":"10.1016\/j.trsl.2015.12.009_bib10","first-page":"597","article-title":"Hepatocyte growth factor and its receptor, the tyrosine kinase encoded by the c-MET proto-oncogene","volume":"40","author":"Vigna","year":"1994","journal-title":"Cell Mol Biol"},{"key":"10.1016\/j.trsl.2015.12.009_bib11","doi-asserted-by":"crossref","first-page":"3074","DOI":"10.1101\/gad.242602","article-title":"CD44 is required for two consecutive steps in HGF\/c-Met signaling","volume":"16","author":"Orian-Rousseau","year":"2002","journal-title":"Genes Dev"},{"key":"10.1016\/j.trsl.2015.12.009_bib12","doi-asserted-by":"crossref","first-page":"7856","DOI":"10.1074\/jbc.M113.505065","article-title":"Overexpression of c-Met and CD44v6 receptors contributes to autocrine TGF-\u03b21 signaling in interstitial lung disease","volume":"289","author":"Ghatak","year":"2014","journal-title":"J Biol Chem"},{"key":"10.1016\/j.trsl.2015.12.009_bib13","doi-asserted-by":"crossref","first-page":"643","DOI":"10.1016\/S0092-8674(01)00567-0","article-title":"A signaling adapter function for alpha6beta4 integrin in the control of HGF-dependent invasive growth","volume":"107","author":"Trusolino","year":"2001","journal-title":"Cell"},{"key":"10.1016\/j.trsl.2015.12.009_bib14","doi-asserted-by":"crossref","first-page":"29384","DOI":"10.1074\/jbc.M706314200","article-title":"Hepatocyte growth factor receptor c-MET is associated with FAS and when activated enhances drug-induced apoptosis in pediatric B acute lymphoblastic leukemia with TEL-AML1 translocation","volume":"282","author":"Accordi","year":"2007","journal-title":"J Biol Chem"},{"key":"10.1016\/j.trsl.2015.12.009_bib15","doi-asserted-by":"crossref","first-page":"720","DOI":"10.1038\/ncb843","article-title":"The semaphorin 4D receptor controls invasive growth by coupling with Met","volume":"4","author":"Giordano","year":"2002","journal-title":"Nat Cell Biol"},{"key":"10.1016\/j.trsl.2015.12.009_bib16","first-page":"1877","article-title":"Expression of hepatocyte growth factor and its receptor (c-met) in skin fibroblasts from patients with systemic sclerosis","volume":"29","author":"Kawaguchi","year":"2002","journal-title":"J Rheumatol"},{"key":"10.1016\/j.trsl.2015.12.009_bib17","doi-asserted-by":"crossref","first-page":"1451","DOI":"10.1016\/S0002-9440(10)64096-5","article-title":"c-MET expression in myofibroblasts: role in autocrine activation and prognostic significance in lung adenocarcinoma","volume":"158","author":"Tokunou","year":"2001","journal-title":"Am J Pathol"},{"key":"10.1016\/j.trsl.2015.12.009_bib18","doi-asserted-by":"crossref","first-page":"752","DOI":"10.1038\/sj.cdd.4402080","article-title":"Amplification of apoptosis through sequential caspase cleavage of the MET tyrosine kinase receptor","volume":"14","author":"Foveau","year":"2007","journal-title":"Cell Death Differ"},{"key":"10.1016\/j.trsl.2015.12.009_bib19","doi-asserted-by":"crossref","first-page":"1017","DOI":"10.1016\/S0002-9440(10)62323-1","article-title":"Growth inhibition and apoptosis in liver myofibroblasts promoted by hepatocyte growth factor leads to resolution from liver cirrhosis","volume":"166","author":"Kim","year":"2005","journal-title":"Am J Pathol"},{"key":"10.1016\/j.trsl.2015.12.009_bib20","doi-asserted-by":"crossref","first-page":"7320","DOI":"10.1074\/jbc.M008363200","article-title":"Executioner caspase-3, -6, and -7 perform distinct, non-redundant roles during the demolition phase of apoptosis","volume":"276","author":"Slee","year":"2001","journal-title":"J Biol Chem"},{"key":"10.1016\/j.trsl.2015.12.009_bib21","doi-asserted-by":"crossref","first-page":"1016","DOI":"10.1038\/ni976","article-title":"Caspase-3 regulates cell cycle in B cells: a consequence of substrate specificity","volume":"4","author":"Woo","year":"2003","journal-title":"Nat Immunol"},{"key":"10.1016\/j.trsl.2015.12.009_bib22","doi-asserted-by":"crossref","first-page":"1310","DOI":"10.1182\/blood-2002-03-0686","article-title":"Platelet formation is the consequence of caspase activation within megakaryocytes","volume":"100","author":"De Botton","year":"2002","journal-title":"Blood"},{"key":"10.1016\/j.trsl.2015.12.009_bib23","doi-asserted-by":"crossref","first-page":"871","DOI":"10.1007\/s00296-009-1068-3","article-title":"Autoantibody against caspase-3, an executioner of apoptosis, in patients with systemic sclerosis","volume":"30","author":"Okazaki","year":"2010","journal-title":"Rheumatol Int"},{"key":"10.1016\/j.trsl.2015.12.009_bib24","doi-asserted-by":"crossref","first-page":"e871","DOI":"10.1038\/cddis.2013.377","article-title":"Caspase-generated fragment of the Met receptor favors apoptosis via the intrinsic pathway independently of its tyrosine kinase activity","volume":"4","author":"Lefebvre","year":"2013","journal-title":"Cell Death Dis"},{"key":"10.1016\/j.trsl.2015.12.009_bib25","doi-asserted-by":"crossref","first-page":"2010","DOI":"10.1002\/hep.26769","article-title":"Novel death defying domain in Met entraps the active site of caspase-3 and blocks apoptosis in hepatocytes","volume":"59","author":"Ma","year":"2014","journal-title":"Hepatology"},{"key":"10.1016\/j.trsl.2015.12.009_bib26","doi-asserted-by":"crossref","first-page":"2737","DOI":"10.1002\/art.38098","article-title":"2013 classification criteria for systemic sclerosis: an American College of Rheumatology\/European League against Rheumatism collaborative initiative","volume":"65","author":"Van den Hoogen","year":"2013","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.trsl.2015.12.009_bib27","doi-asserted-by":"crossref","first-page":"45184","DOI":"10.1074\/jbc.M106441200","article-title":"Thrombin differentiates normal lung fibroblast to a myofibroblast phenotype via proteolytically activated receptor-1 and protein kinase C-dependent pathway","volume":"276","author":"Bogatkevich","year":"2001","journal-title":"J Biol Chem"},{"key":"10.1016\/j.trsl.2015.12.009_bib28","doi-asserted-by":"crossref","first-page":"3468","DOI":"10.1002\/art.22874","article-title":"Down-regulation of collagen and connective tissue growth factor expression with hepatocyte growth factor in lung fibroblasts from white scleroderma patients via two signaling pathways","volume":"56","author":"Bogatkevich","year":"2007","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.trsl.2015.12.009_bib29","doi-asserted-by":"crossref","first-page":"1416","DOI":"10.1002\/art.30255","article-title":"Anti-inflammatory and antifibrotic effects of the oral direct thrombin inhibitor dabigatran etexilate in a murine model of interstitial lung disease","volume":"63","author":"Bogatkevich","year":"2011","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.trsl.2015.12.009_bib30","doi-asserted-by":"crossref","first-page":"467","DOI":"10.1136\/jcp.41.4.467","article-title":"Simple method of estimating severity of pulmonary fibrosis on a numerical scale","volume":"41","author":"Ashcroft","year":"1988","journal-title":"J Clin Pathol"},{"key":"10.1016\/j.trsl.2015.12.009_bib31","doi-asserted-by":"crossref","first-page":"953","DOI":"10.1016\/j.addr.2009.06.001","article-title":"Recent advances in the use of cell-penetrating peptides for medical and biological applications","volume":"61","author":"Fonseca","year":"2009","journal-title":"Adv Drug Deliv Rev"},{"key":"10.1016\/j.trsl.2015.12.009_bib32","doi-asserted-by":"crossref","first-page":"W423","DOI":"10.1093\/nar\/gks398","article-title":"PepSite: prediction of peptide-binding sites from protein surfaces","volume":"40","author":"Trabuco","year":"2012","journal-title":"Nucleic Acids Res"},{"key":"10.1016\/j.trsl.2015.12.009_bib33","doi-asserted-by":"crossref","first-page":"136","DOI":"10.1111\/cbdd.12055","article-title":"The future of peptide-based drugs","volume":"81","author":"Craik","year":"2013","journal-title":"Chem Biol Drug Des"},{"key":"10.1016\/j.trsl.2015.12.009_bib34","doi-asserted-by":"crossref","first-page":"192","DOI":"10.2174\/1389201015666140617093331","article-title":"Cell penetrating peptides and the mechanisms for intracellular entry","volume":"15","author":"Choi","year":"2014","journal-title":"Curr Pharm Biotechnol"},{"key":"10.1016\/j.trsl.2015.12.009_bib35","doi-asserted-by":"crossref","first-page":"226","DOI":"10.2741\/s22","article-title":"Transforming growth factor-beta in systemic sclerosis (scleroderma)","volume":"1","author":"Varga","year":"2009","journal-title":"Front Biosci (Schol Ed)"},{"key":"10.1016\/j.trsl.2015.12.009_bib36","doi-asserted-by":"crossref","first-page":"1249","DOI":"10.1016\/S1357-2725(99)00093-X","article-title":"The Smads","volume":"31","author":"Hill","year":"1999","journal-title":"Int J Biochem Cell Biol"},{"key":"10.1016\/j.trsl.2015.12.009_bib37","doi-asserted-by":"crossref","first-page":"813","DOI":"10.1016\/j.molcel.2004.07.016","article-title":"Structural basis of heteromeric Smad protein assembly in TGF-beta signaling","volume":"15","author":"Chacko","year":"2004","journal-title":"Mol Cell"},{"key":"10.1016\/j.trsl.2015.12.009_bib38","doi-asserted-by":"crossref","first-page":"188","DOI":"10.1016\/j.str.2009.11.012","article-title":"The structural basis of peptide-protein binding strategies","volume":"18","author":"London","year":"2010","journal-title":"Structure"},{"key":"10.1016\/j.trsl.2015.12.009_bib39","doi-asserted-by":"crossref","first-page":"1733","DOI":"10.1038\/sj.jid.5700303","article-title":"Intracellular TGF-beta receptor blockade abrogates Smad-dependent fibroblast activation in\u00a0vitro and in\u00a0vivo","volume":"126","author":"Ishida","year":"2006","journal-title":"J Invest Dermatol"},{"key":"10.1016\/j.trsl.2015.12.009_bib40","first-page":"e001","article-title":"Lung involvement in scleroderma","volume":"S1","author":"Bogatkevich","year":"2012","journal-title":"Rheumatol Curr Res"},{"key":"10.1016\/j.trsl.2015.12.009_bib41","doi-asserted-by":"crossref","first-page":"630","DOI":"10.1097\/BOR.0000000000000111","article-title":"Update on scleroderma-associated interstitial lung disease","volume":"26","author":"Fan","year":"2014","journal-title":"Curr Opin Rheumatol"},{"key":"10.1016\/j.trsl.2015.12.009_bib42","doi-asserted-by":"crossref","first-page":"362","DOI":"10.1016\/j.biocel.2007.08.011","article-title":"The bleomycin animal model: a useful tool to investigate treatment options for idiopathic pulmonary fibrosis?","volume":"40","author":"Moeller","year":"2008","journal-title":"Int J Biochem Cell Biol"},{"key":"10.1016\/j.trsl.2015.12.009_bib43","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1002\/path.2277","article-title":"Cellular and molecular mechanisms of fibrosis","volume":"214","author":"Wynn","year":"2008","journal-title":"J Pathol"},{"key":"10.1016\/j.trsl.2015.12.009_bib44","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1016\/j.drudis.2009.10.009","article-title":"Synthetic therapeutic peptides: science and market","volume":"15","author":"Vlieghe","year":"2010","journal-title":"Drug Discov Today"}],"container-title":["Translational Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S193152441500451X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S193152441500451X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2019,9,2]],"date-time":"2019-09-02T19:16:01Z","timestamp":1567451761000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S193152441500451X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,4]]},"references-count":44,"alternative-id":["S193152441500451X"],"URL":"https:\/\/doi.org\/10.1016\/j.trsl.2015.12.009","relation":{},"ISSN":["1931-5244"],"issn-type":[{"value":"1931-5244","type":"print"}],"subject":[],"published":{"date-parts":[[2016,4]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"M10, a caspase cleavage product of the hepatocyte growth factor receptor, interacts with Smad2 and demonstrates antifibrotic properties in\u00a0vitro and in\u00a0vivo","name":"articletitle","label":"Article Title"},{"value":"Translational Research","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.trsl.2015.12.009","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2016 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}